Mayer Schrieber, CEO of Discovery Park, looks at the current situation of Life Sciences and forecasts what steps need to be taken in 2023 to move the sector forward.
GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research, NUS, NTU Singapore and SITT to boost Singapore's biologics manufacturing capabilities.
EPM speaks to technology company Lifebit about its collaboration with pharmaceutical organisation Boehringer to report on infectious disease outbreaks.
Ipsen Pharmaceuticals and rare disease digital health specialists, Mendelian, has launched a new partnership to utilise Mendelian’s MendelScan software, a Class 1 Medical Device capable of aiding the rapid identification of people with rare diseases.
The Centre for Process Innovation has announced a collaboration with major pharma players GSK and AstraZeneca to create a continuous wet granulation manufacturing facility for oral solid dosage pharmaceuticals.
Antimicrobial resistance (AMR) is one of the biggest threats facing the world but arguably not enough is being done by both pharma companies and governments around the world.
Global specialty pharma company, Theramex, and private pharma company, Endoceutics, have entered into a definitive agreement for the exclusive licensing of Intrarosa (Prasterone) in Europe, Australia, Russia and the Ukraine.
Contract research organisation (CRO), Reaction Biology, has partnered with an open science drug discovery and development company, M4K Pharma, in the fight against diffuse intrinsic pontine glioma (DIPG) — a rare paediatric brain cancer.
The Mundipharma network of independent associated companies has expanded its partnership with biopharma company Celltrion Healthcare to now include exclusive distribution rights to trastuzumab biosimilar, Herzuma, in seven EU markets.
The collaboration between AstraZeneca and TissUse is progressing with the establishment of relevant microphysiological system (MPS) models based on TissUse’s multi-organ-chip technology, the companies announced.
